Dentsply Sirona (XRAY) Common Equity (2009 - 2026)

Dentsply Sirona (XRAY) has reported Common Equity for 18 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity fell 31.11% year-over-year to $1.4 billion; the trailing twelve-month figure through Jun 2026 stood at $1.4 billion (down 31.11% YoY), and the FY2025 full-year result was $1.3 billion, down 31.03% from the prior year.
• Common Equity advanced to $1.4 billion in Q2 2026 per XRAY's latest filing, from $1.3 billion in the prior quarter.
• Across five years, Common Equity topped out at $4.9 billion in Q1 2022 and bottomed at $1.3 billion in Q1 2026.
• Historically, Common Equity has averaged $2.9 billion across 5 years, with a median of $3.2 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: Common Equity retreated 0.53% in 2022, then slumped 41.01% in 2024.
• Over 5 years, Common Equity stood at $3.8 billion in 2022, then retreated by 13.59% to $3.3 billion in 2023, then tumbled by 41.01% to $1.9 billion in 2024, then tumbled by 31.03% to $1.3 billion in 2025, then rose by 0.82% to $1.4 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $1.4 billion, $1.3 billion, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.